Skip to main content

Advertisement

Log in

Efficacy of Growth Hormone Treatment in Children With Chronic Kidney Disease: Tunisian Experience

  • Research Paper
  • Published:
Indian Pediatrics Aims and scope Submit manuscript

Abstract

Objective

To study the effect of using recombinant human growth hormone (rhGH) in growth retarded children with chronic kidney disease (CKD)

Methods

This was a non-randomized controlled study over 2 years including children in CKD stages 4–5 suffering from growth retardation. Children were divided into rhGH-treated or non-rhGH treated groups.

Results

A total of 70 children (35 in each group) were enrolled. While the mean (SD) height of 35 children with CKD had increased from 109.5 (26) cm to 116 (26) cm (mean growth velocity 6.5 cm/year; P=0.09) prior to rhGH therapy, the same was found to increase from 116 (26) cm at the start of therapy to 125 (25) cm after one year of therapy (P=0.02).

Conclusions

Therapy with rhGH was helpful in catch-up growth in Tunisian children with CKD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Stevens PE, Levin A. Evaluation and management of chronic kidney disease: Synopsis of the kidney disease: improving global outcomes 2012 clinical practice guidelines. Ann Intern Med. 2013;158:825–30.

    Article  Google Scholar 

  2. Ingulli EG, Mak RH. Growth in children with chronic kidney disease: Role of nutrition, growth hormone, dialysis and steroids. Curr Opin Pediatr. 2014;26:187–92.

    Article  CAS  Google Scholar 

  3. Mian A, Schwartz GJ. Measurement and estimation of glomerular filtration rate in children. Adv Chronic Kidney Dis. 2017;24:348–56.

    Article  Google Scholar 

  4. KDOQI Work Group. KDOQI Clinical Practice Guideline for Nutrition in Children with CKD: 2008 update. Executive summary. Am J Kidney Dis. 2009;53:S11–104.

    Google Scholar 

  5. Locatelli F, Bárány P, Covic A, et al. Kidney Disease: Improving Global Outcomes guidelines on Anaemia Management in Chronic Kidney Disease: A European Renal Best Practice Position statement. Nephrol Dial Transplant. 2013;28:1346–59.

    Article  CAS  Google Scholar 

  6. Uhlig K, Berns JS, Kestenbaum B, et al. KADOQI US commentary on the KDIGO clinical practice guidelines for the diagnosis, evaluation, and treatment of CKD-mineral and bone disorder. Am J Kidney Disease. 2010;55:773–99.

    Article  Google Scholar 

  7. Ismaili K, Schurmans T, Wissing KM, et al. Early prognostic factors of infants with chronic renal failure caused by renal dysplasia. Pediatr Nephrol. 2001;16:260–4.

    Article  CAS  Google Scholar 

  8. Zivienjak M, Franke D, Filler G, et al. Growth impairment shows an age-dependent pattern in boys with chronic kidney disease. Pediatr Nephrol. 2007;22:420–9.

    Article  Google Scholar 

  9. Karlberg J, Schaefer F, Hennicke M, Wingen AM, Rigden S, Mehls O. European Study Group for Nutritional Treatment of Chronic Renal Failure in Childhood. Early age- dependent growth impairment in chronic renal failure. Pediatr Nephrol. 1999;10:283

    Article  Google Scholar 

  10. Marlais M, Stojanovic J, Jones H, et al. Catch-up growth in children with chronic kidney disease started on enteral feeding after 2 years of age. Pediatr Nephrol. 2020;35:113–18.

    Article  Google Scholar 

  11. Van Dyck M, Bilem N, Proesmans W. Conservative treatment for chronic renal failure from birth: A 3-year follow-up study. Pediatr Nephrol. 1999;13:865–86919.

    Article  CAS  Google Scholar 

  12. Larson-Nath C, Goday P. Malnutrition in children with chronic disease. Nutr Clin Pract. 2019;34:349–58.

    Article  Google Scholar 

  13. Franz S. Section XI — Chronic kidney disease-endocrine and growth disorders in chronic renal failure. In: Avner, Ellis D, Harmon, William E, Niaudet P, eds. Pediatric Nephrology 5th Ed. Lippincott Williams & Wilkins; 2004. p.1313–45.

  14. Drube J, Wan M, Bonthuis M, et al. Clinical practice recommendations for growth hormone treatment in children with chronic kidney disease. Nat Rev Nephrol. 2019;15: 577–89.

    Article  CAS  Google Scholar 

  15. Rhie YJ, Yoo JH, Choi JH, et al. Long-term safety and effectiveness of growth hormone therapy in Korean children with growth disorders: 5-year results of LG growth study. PLoS One. 2019;14:e0216927.

    Article  CAS  Google Scholar 

Download references

Funding

Funding: None

Author information

Authors and Affiliations

Authors

Contributions

Contributors: AB: concept and designed the study, analyzed data and drafted the manuscript; RL: collected the data, helped in data analysis; MJ: helped in collecting data, and manuscript drafting; ON: supervised cognitive and behavioral assessments; TG: supervised cognitive and behavioral assessments

Corresponding author

Correspondence to Abir Boussetta.

Ethics declarations

Ethics clearance: Ethic committee of Charles Nicolle Hospital; No. Tun23032016, dated March 23, 2016.

Competing interest: None stated.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Boussetta, A., Laamouri, R., Jellouli, M. et al. Efficacy of Growth Hormone Treatment in Children With Chronic Kidney Disease: Tunisian Experience. Indian Pediatr 58, 1140–1142 (2021). https://doi.org/10.1007/s13312-021-2395-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13312-021-2395-z

Keywords

Navigation